This is interesting and potentially very important.
The nanotherapy drug Xenavex, is a NFkB and AP-1 blocker. But it does a litle more, and the "little more" is the current focus of ongoing research. What it does, and they're not sure why, is targets cells with a p53 defect. In such cells, the drug activates the p53 function, hence, it's an apoptosis promoter.
There are a number of clinics using melatonin (mainstream Europe) and PSK (used for 20 years in Japan), two items on PubMed and elsewhere, that neither destroy organs and ruin the immune system. In fact, both enhance the immune system.
http://www.medicalnewstoday.com/medi...p?newsid=70633